[图书][B] Clinical anesthesia
PG Barash - 2009 - books.google.com
The premier single-volume reference in the field of anesthesia, Clinical Anesthesia is now in
its Sixth Edition, with thoroughly updated coverage, a new full-color design, and a revamped …
its Sixth Edition, with thoroughly updated coverage, a new full-color design, and a revamped …
[HTML][HTML] Effect of mode of intraoperative support on primary graft dysfunction after lung transplant
G Loor, S Huddleston, M Hartwig, B Bottiger… - The Journal of Thoracic …, 2022 - Elsevier
Objective To clarify the relationship between the use of extracorporeal life support during
lung transplantation and severe primary graft dysfunction (PGD), we developed and …
lung transplantation and severe primary graft dysfunction (PGD), we developed and …
[HTML][HTML] CCR5 drives NK cell–associated airway damage in pulmonary ischemia-reperfusion injury
J Santos, P Wang, A Shemesh, F Liu, T Tsao… - JCI insight, 2023 - ncbi.nlm.nih.gov
Primary graft dysfunction (PGD) limits clinical benefit after lung transplantation, a life-
prolonging therapy for patients with end-stage disease. PGD is the clinical syndrome …
prolonging therapy for patients with end-stage disease. PGD is the clinical syndrome …
Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis
The clinical use of circulating biomarkers for primary graft dysfunction (PGD) after lung
transplantation has been limited. In a prospective single-center cohort, we examined the use …
transplantation has been limited. In a prospective single-center cohort, we examined the use …
MICB Genomic Variant Is Associated with NKG2D-mediated Acute Lung Injury and Death
OA Aguilar, AE Qualls… - American Journal of …, 2024 - atsjournals.org
Rationale: Acute lung injury (ALI) carries a high risk of mortality but has no established
pharmacologic therapy. We previously found that experimental ALI occurs through natural …
pharmacologic therapy. We previously found that experimental ALI occurs through natural …
[HTML][HTML] Xenotransplantation of mitochondria: A novel strategy to alleviate ischemia-reperfusion injury during ex vivo lung perfusion
Background Ischemia-reperfusion injury (IRI) plays a crucial role in the development of
primary graft dysfunction (PGD) following lung transplantation. A promising novel approach …
primary graft dysfunction (PGD) following lung transplantation. A promising novel approach …
Impact of pre‐lung transplant statin use on the development of primary graft dysfunction
V Yuenger, S January, K Fester… - … : The Journal of …, 2023 - Wiley Online Library
Background Primary graft dysfunction (PGD) is a common occurrence following lung
transplantation and contributes to short‐and long‐term morbidity and mortality. Current …
transplantation and contributes to short‐and long‐term morbidity and mortality. Current …
Transient receptor potential vanilloid 4 channel inhibition attenuates lung ischemia-reperfusion injury in a porcine lung transplant model
RJ Strobel, HQ Ta, AM Young, AM Wisniewski… - The Journal of Thoracic …, 2024 - Elsevier
Objective Transient receptor potential vanilloid 4 (TRPV4) is a nonselective cation channel
important in many physiological and pathophysiological processes, including pulmonary …
important in many physiological and pathophysiological processes, including pulmonary …
基于灰阶超声影像组学在鉴别膀胱尿路上皮癌病理分级中的应用价值
王丹, 任瑞民, 任雯, 陈秀斌, 姚浮成, 薛继平 - 分子影像学杂志, 2024 - j-fzyx.com
目的通过灰阶超声影像组学特征鉴别膀胱尿路上皮癌病理分级. 方法回顾性分析2016 年4 月~
2023 年5 月山西白求恩医院153 例经病理证实的膀胱尿路上皮癌患者. 灰阶超声图像手工勾画 …
2023 年5 月山西白求恩医院153 例经病理证实的膀胱尿路上皮癌患者. 灰阶超声图像手工勾画 …
Impact of the New Definition of Pulmonary Hypertension on the Prevalence of Primary Graft Dysfunction in Lung Transplant Recipients
VM Mora-Cuesta, A Martínez-Meñaca… - Heart, Lung and …, 2024 - Elsevier
Background & Aim Pulmonary hypertension (PH) secondary to lung disease (Group-3 PH) is
the second leading cause of PH. The role of PH as a risk factor for primary graft dysfunction …
the second leading cause of PH. The role of PH as a risk factor for primary graft dysfunction …